In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity
Its specialised listing pathways continue to provide issuers at different stages of development with flexibility, in addition to offering access to a sophisticated healthcare investor base
In addition, terminal sterilization, which is a regulatory requirement, presents further challenges because conventional methods such as autoclaving, gamma irradiation, or filtration may damage lipid structures or degrade peptide integrity
The results below are based on 8,049 responses collected in November/December 2021
Having Mason move in with him full-time has been a complete game changer, the source added